| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-10 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-07 |